Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $157.5852W HIGH $283.05
Volume
525.58 K
Value Traded
231.51 M
Short % Float
2.53%
+1.66%Week
+0.03%1 Month
+35.4%3 Month
+36.68%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
21.24 B
EPS (TTM)
39.42
P/E Ratio
6.69
Ent. Value
19.07 B
Total Shares
80.48 M
Float Shares
79.75 M
Insiders
0.95%
Institutions
100.43%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
THC Catalyst Timeline
Dated clinical, regulatory and corporate events for Tenet Healthcare Corporation New
Catalyst Timeline
Dated clinical, regulatory & corporate events for Tenet Healthcare Corporation New
2Total events
0Upcoming
0Tier-1 (high impact)
2026 to 2026Coverage
Event history 1
Past FDA Catalysts and PDUFA Decisions
How THC actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Tenet Healthcare Corporation New is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every THC program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| KERREY J ROBERTDirector | Sell | -5,483 11,321 held | $263.04 | 09/14/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in THC
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 1.2 % (20 %) | 30.87 M | 165.00 K | 65% ( 65.00 K) |
THC Institutional Ownership Trends
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2028-01-21 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How THC ranks across every disease it competes in
Competitive Position is a premium feature
See how THC ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialTHC News
-THC
Oct 2, 2026Tenet to Report Its Third Quarter 2026 Results on October 29
Tenet Healthcare Corporation will announce its third quarter 2026 results on October 29, 2026, prior to market opening. A conference call will follow at 9:00 a.m. CT, allowing investors to engage with the company. The results and call will be accessible through Tenet's investor relations webpage.
Read more →-THC
Sep 8, 2026Tenet Announces Upsizing and Pricing of Its $2.0 Billion Private Offering of Senior Notes
Tenet Healthcare Corporation has successfully upsized its private placement offering of senior notes to $2.0 billion, an increase from the previously announced $1.5 billion. The notes will have an interest rate of 6.250% per annum and are due on September 15, 2034. This move reflects strong investor interest and confidence in the company.
Read more →-THC
Sep 8, 2026Tenet Announces Private Offering of Senior Notes to Refinance $1.5 Billion in Outstanding Notes
Tenet Healthcare Corporation has announced a private placement offering of $1.5 billion in senior notes due 2034. This move aims to refinance an equal amount of currently outstanding notes. The completion of the offering is contingent on pricing and customary closing conditions. The proceeds will be used to finance various corporate needs.
Read more →-THC
Sep 2, 2026Tenet to Participate in the Wells Fargo Healthcare Conference
Tenet Healthcare Corporation is set to present at the Wells Fargo Healthcare Conference on September 9, 2026, at 12:45 p.m. ET. Investors can access a live webcast and audio archive through Tenet's investor relations website, with a replay available for 30 days. This event highlights Tenet's commitment to investor engagement.
Read more →-THC
Jul 23, 2026▲ +17.2%on this news· ran to +29% by day 3
Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
Tenet Healthcare Corporation announced its second quarter 2026 results, highlighting strong same-store revenue growth and effective expense management. CEO Saum Sutaria noted that these factors contributed to the company's outperformance against initial financial expectations. The company is also focusing on operational execution and investments to navigate industry dynamics.
Read more →-THC
Jun 22, 2026Tenet to Report Its Second Quarter 2026 Results on July 24
Tenet Healthcare Corporation (THC) is set to report its second quarter results for 2026 on July 24. This announcement is part of their regular financial reporting schedule. Investors and analysts will be keen to assess the company's performance during this period.
Read more →-THC
May 6, 2026Tenet to Participate in the BofA Securities Health Care Conference
Tenet Healthcare Corporation is set to present at the BofA Securities Health Care Conference on May 13, 2026. The presentation will begin at 6:00 p.m. Eastern Time and will be available via a live webcast. Tenet Healthcare is recognized for its extensive healthcare services, including surgical centers and hospitals.
Read more →-THC
Apr 30, 2026Tenet Reports Strong First Quarter 2026 Results
Tenet Healthcare Corporation reported strong financial results for Q1 2026, with net operating revenues of $5.368 billion and net income of $702 million, significantly up from the previous year. The company's Ambulatory and Hospital segments showed growth, although adjusted EBITDA saw a slight decline. Tenet's outlook for 2026 remains positive, projecting revenues between $21.5 billion and $22.3 billion.
Read more →-THC
Feb 11, 2026▲ +17.3%on this news
Tenet Reports Strong Fourth Quarter and FY 2025 Results Provides 2026 Financial Outlook
Tenet Healthcare Corporation (THC) reported robust financial results for the fourth quarter of 2025, posting a net income of $371 million or $4.22 per diluted share, alongside a notable 36.6% increase in adjusted diluted earnings per share from the previous year. The company achieved a consolidated adjusted EBITDA of $1.183 billion, reflecting a 12.9% growth. For fiscal year 2026, Tenet projects an adjusted EBITDA range between $4.485 billion and $4.785 billion. While the company maintained strong revenue growth, it recorded a decline in annual net income, primarily due to significant prior year gains from hospital divestitures.
Read more →-THC
Feb 2, 2026Tenet Announces Accretive Transaction and Previews Strong 2025 Results
Tenet Healthcare Corporation has completed a transaction with CommonSpirit Health to regain full ownership of Conifer Health Solutions. The deal involves payments totaling approximately $1.9 billion over the next three years, which is expected to enhance Tenet's earnings in 2026. Additionally, Tenet anticipates strong revenue growth and improved cash flow for the year ended December 31, 2025. This agreement allows Conifer to continue supporting CommonSpirit's operations while expanding its focus on technology and innovation in revenue cycle management.
Read more →-THC
Nov 3, 2025Tenet Announces Private Offerings of Senior Secured Notes and Senior Notes to Refinance $2.0 Billion in Outstanding Notes
Tenet Healthcare Corporation (NYSE THC) has announced the private placement of $1.5 billion in senior secured notes and $0.5 billion in senior notes, totaling $2.0 billion. The proceeds will be used to refinance existing debt, aiming to enhance financial stability. These notes will not be registered under the Securities Act, which may restrict the ability to sell them to U.S. persons. The company has outlined risks and uncertainties about its future performance in accompanying statements.
Read more →-THC
Oct 28, 2025▼ -5.3%on this news
Tenet Reports Strong Third Quarter 2025 Results Raises 2025 Financial Outlook
Tenet Healthcare Corporation (THC) reported strong financial results for the third quarter of 2025, highlighting a net income of $342 million, a significant increase in adjusted diluted earnings per share, and a rise in consolidated adjusted EBITDA. The company raised its adjusted EBITDA outlook for the full year 2025, reflecting a commitment to operational growth and cash flow generation. Notably, while the Ambulatory Care segment thrived, the hospital operations faced challenges such as a decrease in admissions and increased pressure on emergency room visits.
Read more →-THC
Jul 22, 2025▼ -10.7%on this news
Tenet Reports Strong Second Quarter 2025 Results Raises 2025 Financial Outlook
Tenet Healthcare Corporation reported strong financial results for the second quarter of 2025, with net income available to shareholders increasing to $288 million. The company raised its financial outlook for the year, projecting adjusted EBITDA of up to $4.54 billion. Notably, adjusted diluted earnings per share surged by 74% compared to the previous year. Investments and a robust free cash flow were highlighted as key components of their ongoing strategy to enhance operational effectiveness.
Read more →-THC
Apr 29, 2025▲ +11.7%on this news
Tenet Reports Strong First Quarter 2025 Results
Tenet Healthcare Corporation reported robust first-quarter results for 2025, achieving a net income of $406 million or $4.27 per diluted share. Adjusted diluted earnings per share surged by 35.4% to $4.36, driven by operational efficiencies and strong revenue growth. The company experienced a consolidated Adjusted EBITDA increase of 13.6%, although net operating revenues declined slightly from the previous year. Management remains positive about future performance, anticipating continued growth in Adjusted EBITDA and revenues for the full fiscal year 2025.
Read more →-THC
Feb 12, 2025▼ -9.1%on this news
Tenet Reports Strong Fourth Quarter and FY 2024 Results Provides 2025 Financial Outlook
Tenet Healthcare Corporation reported strong financial results for the fourth quarter of 2024, highlighting a net income of $318 million and an Adjusted EBITDA of $1.048 billion. The company anticipates continued growth with a financial outlook for 2025 projecting Adjusted EBITDA between $3.975 billion and $4.175 billion. Despite a decline in net operating revenues resulting from hospital divestitures, Tenet's focus on efficient operations and high patient satisfaction levels contributed to their successful performance. Additionally, Tenet's strategic changes in operational management provided momentum for future expectations.
Read more →-THC
Oct 29, 2024▲ +16.7%on this news
Tenet Reports Strong Third Quarter 2024 Results Raises 2024 Financial Outlook Net income available to common shareholders in third quarter 2024 was $472 million, or $4.89 per diluted share, including an after-tax gain of
Tenet Healthcare Corporation reported strong financial results for the third quarter of 2024, with net income rising to $472 million, significantly above the previous year's figures. Adjusted EBITDA grew by 14.5%, supported by improved same-store revenue and profitability. The company increased its full-year Adjusted EBITDA outlook by $50 million to a range of $3.9 billion to $4.0 billion. Despite the positive performance overall, certain challenges were noted, including a decrease in net operating revenues for the hospital segment linked to previously executed divestitures.
Read more →-THC
Aug 5, 2024Tenet Healthcare to Sell Five Birmingham Hospitals to Orlando Health Tenet announces agreement to sell Birmingham hospitals and related operations reaffirms latest FY24 Adjusted EBITDA Outlook DALLAS
Tenet Healthcare Corporation has entered into a definitive agreement with Orlando Health to sell its 70% majority interest in Brookwood Baptist Health, which includes five hospitals in Birmingham, for approximately $910 million. The deal is expected to yield a pre-tax book gain of about $375 million and will be completed in fall 2024, pending regulatory approvals. Additionally, Tenet's Conifer Health Solutions subsidiary will secure a new ten-year contract to manage revenue cycle services for the sold facilities. The agreement positions Orlando Health to enhance its healthcare services in the Birmingham area.
Read more →-THC
Jul 24, 2024Tenet Reports Strong Second Quarter 2024 Results Raises 2024 Financial Outlook Net income available to common shareholders in second quarter 2024 was $259 million, or $2.64 per diluted share Adjusted diluted earnings per
Tenet Healthcare Corporation reported strong financial results for the second quarter of 2024, with a net income of $259 million, reflecting substantial growth from the previous year. The company also announced a new $1.5 billion share repurchase program and raised its Adjusted EBITDA outlook for the year, highlighting solid operating performance and volume growth. However, the Hospital segment experienced a 4.3% decline in net operating revenues, attributed to recent divestitures. Overall, the outlook for the remainder of 2024 remains optimistic despite some challenges in specific segments.
Read more →-THC
Apr 30, 2024▲ +13.3%on this news
Tenet Reports First Quarter 2024 Results Well in Excess of Guidance Raises 2024 Financial Outlook Net income from continuing operations available to common shareholders in first quarter 2024 was $2.151 billion, or $21.38
Tenet Healthcare Corporation reported robust financial results for Q1 2024, achieving net income of $2.151 billion, significantly higher than the previous year's $143 million. The company has raised its full-year 2024 outlook for Adjusted EBITDA to a range of $3.5 billion to $3.7 billion, reflecting strong growth in revenues and profitability. The results were bolstered by a substantial after-tax gain from hospital divestitures and effective operational management, including improvements in admission rates and contract labor costs.
Read more →About Tenet Healthcare Corporation New
Headquarters14201 DALLAS PARKWAY, DALLAS, TX, 75254
BIOPHARMAWATCH ELITE PLUS
Trade the next THC catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime